Copyright
©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 813-825
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Overall population (n = 11441) | NAFLD population (n = 4159) | |||||
Normal ALT level (n = 9698) | Elevated ALT level (n = 1743) | P value | Normal ALT level (n = 3131) | Elevated ALT level (n = 1028) | P value | |
Age (yr) | 44.4 ± 0.17 | 41.5 ± 0.35 | < 0.001 | 48.0 ± 0.29 | 43.2 ± 0.45 | < 0.001 |
Sex, male (%) | 4397 (45.3) | 710 (40.7) | < 0.001 | 1496 (47.8) | 436 (42.4) | 0.003 |
Race/ethnicity, n (%) | < 0.001 | < 0.001 | ||||
Non-Hispanic White | 3725 (38.4) | 527 (30.2) | 1186 (37.9) | 300 (29.2) | ||
Non-Hispanic Black | 2950 (30.4) | 325 (18.6) | 861 (27.5) | 143 (13.9) | ||
Mexican American | 2620 (27.0) | 815 (46.8) | 967 (30.9) | 540 (52.5) | ||
Others | 403 (4.2) | 76 (4.4) | 117 (3.7) | 45 (4.4) | ||
Waist circumference (cm) | 92.3 ± 0.15 | 98.3 ± 0.35 | < 0.001 | 97.9 ± 0.30 | 102.6 ± 0.45 | < 0.001 |
BMI (kg/m2) | 27.0 ± 0.06 | 29.7 ± 0.15 | < 0.001 | 28.9 ± 0.12 | 31.4 ± 0.20 | < 0.001 |
Hypertension, n (%) | 3892 (40.1) | 698 (40.0) | 0.946 | 1434 (45.8) | 458 (44.6) | 0.486 |
Diabetes, n (%) | 836 (8.6) | 253 (14.5) | < 0.001 | 476 (15.2) | 214 (20.8) | < 0.001 |
HOMA-IR, n (%) | 3652 (37.7) | 1117 (64.1) | < 0.001 | 1712 (54.7) | 785 (76.4) | < 0.001 |
Fasting plasma glucose (mmol/L) | 5.6 ± 0.02 | 5.9 ± 0.06 | < 0.001 | 6.0 ± 0.05 | 6.3 ± 0.09 | 0.002 |
HbA1c (%) | 5.5 ± 0.01 | 5.7 ± 0.03 | < 0.001 | 5.8 ± 0.02 | 5.9 ± 0.05 | 0.027 |
TG (mg/dL) | 135.2 ± 1.0 | 182.4 ± 3.2 | < 0.001 | 165.9 ± 2.09 | 207.0 ± 4.49 | < 0.001 |
Total cholesterol (mg/dL) | 204.2 ± 0.44 | 209.7 ± 1.07 | < 0.001 | 208.6 ± 0.80 | 212.6 ± 1.37 | < 0.001 |
HDL (mg/dL) | 51.3 ± 0.15 | 47.0 ± 0.36 | < 0.001 | 48.3 ± 0.27 | 45.0 ± 0.47 | < 0.001 |
ALT (IU/L) | 13.7 ± 0.06 | 39.5 ± 0.63 | < 0.001 | 14.9 ± 0.10 | 41.7 ± 0.90 | < 0.001 |
AST (IU/L) | 19.0 ± 0.06 | 34.2 ± 0.64 | < 0.001 | 19.5 ± 0.11 | 35.6 ± 0.92 | < 0.001 |
Albumin (g/L) | 41.4 ± 0.04 | 41.7 ± 0.09 | 0.007 | 41.1 ± 0.07 | 41.8 ± 0.11 | < 0.001 |
Smoked at least 100 cigarettes, n (%) | 4872 (50.2) | 752 (43.3) | < 0.001 | 1637 (52.3) | 448 (43.6) | < 0.001 |
Sedentary lifestyle, n (%) | 2811 (29.0) | 583 (33.4) | < 0.001 | 1048 (33.5) | 373 (36.3) | 0.099 |
NAFLD, n (%) | 3131 (32.3) | 1028 (59.0) | < 0.001 | |||
Mild | 1326 (13.7) | 229 (13.1) | 1326 (42.4) | 229 (22.3) | ||
Moderate | 1268 (13.1) | 490 (28.1) | 1268 (40.5) | 490 (47.7) | ||
Severe | 537 (5.5) | 309 (1.7) | < 0.001 | 537 (17.2) | 309 (30.1) | < 0.001 |
- Citation: Zheng JR, Wang ZL, Jiang SZ, Chen HS, Feng B. Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World J Hepatol 2023; 15(6): 813-825
- URL: https://www.wjgnet.com/1948-5182/full/v15/i6/813.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i6.813